Table 3.
Cox regression model to predict tumor recurrence, FAS population (n = 502).
Univariate Analysis | Hazard Ratio | 95% CI | p-Value |
High- vs. intermediate-risk group | 1.322 | 0.968–1.805 | 0.0783 |
T1 vs. Ta | 1.44 | 1.019–2.037 | 0.0009 |
Primary cis vs. T1 | 2.609 | 1.177–5.784 | |
Primary cis vs. Ta | 3.758 | 1.746–8.088 | |
G2 vs. G1 | 1.088 | 0.733–1.615 | 0.1065 |
G3 vs. G2 | 1.347 | 0.927–1.956 | |
G3 vs. G1 | 1.466 | 1.003–2.145 | |
Cis vs. no cis | 2.551 | 1.472–4.424 | 0.0008 |
Recurrent vs. primary | 1.756 | 1.285–2.399 | 0.0004 |
Treatment duration < 4 vs. ≥4 months | 1.842 | 1.321–2.568 | 0.0003 |
No maintenance vs. maintenance | 1.929 | 1.307–2.846 | 0.0009 |
Previous MMC vs. no | 1.611 | 1.071–2.424 | 0.0299 |
Previous BCG vs. no | 1.834 | 1.187–2.84 | 0.0063 |
Age ≥ 70 vs. <70 years | 1.254 | 0.917–1.715 | 0.156 |
Male vs. female | 1.326 | 0.852–2.061 | 0.2102 |
Smoker vs. non-smoker | 1.274 | 0.81–2.004 | 0.2948 |
Multiple vs. single tumor | 1.220 | 0.888–1.675 | 0.2199 |
Size ≥ 3 vs. <3 cm | 1.024 | 0.724–1.449 | 0.8895 |
Multivariate analysis | Hazard Ratio | 95% CI | p-value |
Recurrent vs. primary | 1.828 | 1.327–2.518 | 0.0002 |
Treatment duration < 4 vs. ≥4 months | 1.724 | 1.235–2.407 | 0.0014 |
High- vs. intermediate-risk group | 1.472 | 1.071–2.024 | 0.0171 |